Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1986 Oct;60(1):294–296. doi: 10.1128/jvi.60.1.294-296.1986

Coxsackievirus B3 infection alters plasma membrane of neonatal skin fibroblasts.

C W Lutton, C J Gauntt
PMCID: PMC253929  PMID: 3018294

Abstract

Replication of coxsackievirus B3 occurred for days in cultures of murine neonatal skin fibroblasts in the absence of cytopathology and resulted in alteration of the plasma membrane. Dual immunofluorescence studies showed that the lectin Ulex europaeus agglutinin I bound only to cells producing viral capsid antigens. Cultures of coxsackievirus B3-inoculated murine neonatal skin fibroblasts showed maximum binding of this lectin at 72 h postinoculation. These data show that in a nonlytic infection a picornavirus can alter the surface of an infected cell.

Full text

PDF
294

Images in this article

295Image
on p.295

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burch G. E., Giles T. D. The role of viruses in the production of heart disease. Am J Cardiol. 1972 Feb;29(2):231–240. doi: 10.1016/0002-9149(72)90634-0. [DOI] [PubMed] [Google Scholar]
  2. Gauntt C. J., Gomez P. T., Duffey P. S., Grant J. A., Trent D. W., Witherspoon S. M., Paque R. E. Characterization and myocarditic capabilities of coxsackievirus B3 variants in selected mouse strains. J Virol. 1984 Nov;52(2):598–605. doi: 10.1128/jvi.52.2.598-605.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gauntt C. J., Paque R. E., Trousdale M. D., Gudvangen R. J., Barr D. T., Lipotich G. J., Nealon T. J., Duffey P. S. Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis. Infect Immun. 1983 Feb;39(2):851–864. doi: 10.1128/iai.39.2.851-864.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gauntt C. J., Trousdale M. D., LaBadie D. R., Paque R. E., Nealon T. Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice. J Med Virol. 1979;3(3):207–220. doi: 10.1002/jmv.1890030307. [DOI] [PubMed] [Google Scholar]
  5. Goldstein I. J., Hayes C. E. The lectins: carbohydrate-binding proteins of plants and animals. Adv Carbohydr Chem Biochem. 1978;35:127–340. doi: 10.1016/s0065-2318(08)60220-6. [DOI] [PubMed] [Google Scholar]
  6. Lansdown A. B. Viral Infections and diseases of the heart. Prog Med Virol. 1978;24:70–113. [PubMed] [Google Scholar]
  7. Lewes D. Viral myocarditis. Practitioner. 1976 Mar;216(1293):281–287. [PubMed] [Google Scholar]
  8. Lutton C. W., Gauntt C. J. Ameliorating effect of IFN-beta and anti-IFN-beta on coxsackievirus B3-induced myocarditis in mice. J Interferon Res. 1985 Winter;5(1):137–146. doi: 10.1089/jir.1985.5.137. [DOI] [PubMed] [Google Scholar]
  9. Lutton C. W., Gudvangen R. J., Nealon T. J., Paque R. E., Gauntt C. J. Cellular immune responses in mice challenged with an amyocarditic variant of Coxsackievirus B3. J Med Virol. 1985 Dec;17(4):345–357. doi: 10.1002/jmv.1890170407. [DOI] [PubMed] [Google Scholar]
  10. Matsumoto I., Osawa T. Purification and characterization of an anti-H(O) phytohemagglutinin of Ulex europeus. Biochim Biophys Acta. 1969 Nov 11;194(1):180–189. doi: 10.1016/0005-2795(69)90193-7. [DOI] [PubMed] [Google Scholar]
  11. McLean I. W., Nakane P. K. Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoelectron microscopy. J Histochem Cytochem. 1974 Dec;22(12):1077–1083. doi: 10.1177/22.12.1077. [DOI] [PubMed] [Google Scholar]
  12. Paque R. E., Gauntt C. J., Nealon T. J. Assessment of cell-mediated immunity against coxsackievirus B3-induced myocarditis in a primate model (Papio papio). Infect Immun. 1981 Jan;31(1):470–479. doi: 10.1128/iai.31.1.470-479.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Paque R. E., Gauntt C. J., Nealon T. J., Trousdale M. D. Assessment of cell-mediated hypersensitivity against coxsackievirus B3 viral-induced myocarditis utilizing hypertonic salt extracts of cardiac tissue. J Immunol. 1978 May;120(5):1672–1678. [PubMed] [Google Scholar]
  14. Paque R. E., Straus D. C., Nealon T. J., Gauntt C. J. Fractionation and immunologic assessment of KCl-extracted cardiac antigens in coxsackievirus B3 virus-induced myocarditis. J Immunol. 1979 Jul;123(1):358–364. [PubMed] [Google Scholar]
  15. Trousdale M. D., Paque R. E., Nealon T., Gauntt C. J. Assessment of coxsackievirus B3 ts mutants for induction of myocarditis in a murine model. Infect Immun. 1979 Feb;23(2):486–495. doi: 10.1128/iai.23.2.486-495.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Wong C. Y., Woodruff J. J., Woodruff J. F. Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. I. Model and viral specificity1. J Immunol. 1977 Apr;118(4):1159–1164. [PubMed] [Google Scholar]
  17. Woodruff J. F. Viral myocarditis. A review. Am J Pathol. 1980 Nov;101(2):425–484. [PMC free article] [PubMed] [Google Scholar]
  18. Yu Z. X., Sekiguchi M., Hiroe M., Take M., Hirosawa K. Histopathological findings of acute and convalescent myocarditis obtained by serial endomyocardial biopsy. Jpn Circ J. 1984 Dec;48(12):1368–1374. doi: 10.1253/jcj.48.1368. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES